STOCK TITAN

Tandem Diabetes (TNDM) Stock News

TNDM Nasdaq

Welcome to our dedicated page for Tandem Diabetes news (Ticker: TNDM), a resource for investors and traders seeking the latest updates and insights on Tandem Diabetes stock.

Tandem Diabetes Care reports developments in automated insulin delivery and diabetes technology. The company manufactures and sells pump systems including Tandem Mobi and the t:slim X2 insulin pump, both powered by Control-IQ+ advanced hybrid closed-loop technology. News commonly covers FDA clearances, pump and mobile-app compatibility, continuous glucose monitoring integrations, and product portfolio updates for people with diabetes.

Company updates also address quarterly and annual operating results, worldwide and U.S. sales trends, pump shipments, gross margin, financial guidance, reimbursement-model changes, investor conference presentations, and capital actions such as convertible debt financing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
private placement
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.96%
Tags
private placement
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.86%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.33%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.51%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.8%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.22%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.22%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.06%
Tags
none

FAQ

What is the current stock price of Tandem Diabetes (TNDM)?

The current stock price of Tandem Diabetes (TNDM) is $17.12 as of July 26, 2026.

What is the market cap of Tandem Diabetes (TNDM)?

The market cap of Tandem Diabetes (TNDM) is approximately 1.2B.